Global Influenza Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The Global Influenza Vaccine Market Size was estimated at USD 5586.54 million in 2023 and is projected to reach USD 7615.76 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.
This report provides a deep insight into the global Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccine market in any manner.
Global Influenza Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The Global Influenza Vaccine Market Size was estimated at USD 5586.54 million in 2023 and is projected to reach USD 7615.76 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.
This report provides a deep insight into the global Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccine market in any manner.
Global Influenza Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Influenza Vaccine Market
- Overview of the regional outlook of the Influenza Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Vaccine
1.2 Key Market Segments
1.2.1 Influenza Vaccine Segment by Type
1.2.2 Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Vaccine Sales Sites, Area Served, Product Type
3.6 Influenza Vaccine Market Competitive Situation and Trends
3.6.1 Influenza Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Influenza Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Vaccine Price by Type (2019-2024)
7 INFLUENZA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccine Market Sales by Application (2019-2024)
7.3 Global Influenza Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Vaccine Sales Growth Rate by Application (2019-2024)
8 INFLUENZA VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Influenza Vaccine Sales by Region
8.1.1 Global Influenza Vaccine Sales by Region
8.1.2 Global Influenza Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Influenza Vaccine Basic Information
9.1.2 Sanofi Influenza Vaccine Product Overview
9.1.3 Sanofi Influenza Vaccine Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Influenza Vaccine SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Influenza Vaccine Basic Information
9.2.2 CSL Influenza Vaccine Product Overview
9.2.3 CSL Influenza Vaccine Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Influenza Vaccine SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Influenza Vaccine Basic Information
9.3.2 GSK Influenza Vaccine Product Overview
9.3.3 GSK Influenza Vaccine Product Market Performance
9.3.4 GSK Influenza Vaccine SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Influenza Vaccine Basic Information
9.4.2 Viatris Influenza Vaccine Product Overview
9.4.3 Viatris Influenza Vaccine Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Influenza Vaccine Basic Information
9.5.2 AstraZeneca Influenza Vaccine Product Overview
9.5.3 AstraZeneca Influenza Vaccine Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Influenza Vaccine Basic Information
9.6.2 Hualan Bio Influenza Vaccine Product Overview
9.6.3 Hualan Bio Influenza Vaccine Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Influenza Vaccine Basic Information
9.7.2 Changchun Institute of Biological Influenza Vaccine Product Overview
9.7.3 Changchun Institute of Biological Influenza Vaccine Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Influenza Vaccine Basic Information
9.8.2 Sinovac Influenza Vaccine Product Overview
9.8.3 Sinovac Influenza Vaccine Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 BCHT
9.9.1 BCHT Influenza Vaccine Basic Information
9.9.2 BCHT Influenza Vaccine Product Overview
9.9.3 BCHT Influenza Vaccine Product Market Performance
9.9.4 BCHT Business Overview
9.9.5 BCHT Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Influenza Vaccine Basic Information
9.10.2 Jiangsu GDK Influenza Vaccine Product Overview
9.10.3 Jiangsu GDK Influenza Vaccine Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Influenza Vaccine Basic Information
9.11.2 KM Biologics Influenza Vaccine Product Overview
9.11.3 KM Biologics Influenza Vaccine Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
10 INFLUENZA VACCINE MARKET FORECAST BY REGION
10.1 Global Influenza Vaccine Market Size Forecast
10.2 Global Influenza Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Vaccine Market Size Forecast by Region
10.2.4 South America Influenza Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2025-2030)
11.1.2 Global Influenza Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Vaccine by Type (2025-2030)
11.2 Global Influenza Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Influenza Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Vaccine
1.2 Key Market Segments
1.2.1 Influenza Vaccine Segment by Type
1.2.2 Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Vaccine Sales Sites, Area Served, Product Type
3.6 Influenza Vaccine Market Competitive Situation and Trends
3.6.1 Influenza Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Influenza Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Vaccine Price by Type (2019-2024)
7 INFLUENZA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccine Market Sales by Application (2019-2024)
7.3 Global Influenza Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Vaccine Sales Growth Rate by Application (2019-2024)
8 INFLUENZA VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Influenza Vaccine Sales by Region
8.1.1 Global Influenza Vaccine Sales by Region
8.1.2 Global Influenza Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Influenza Vaccine Basic Information
9.1.2 Sanofi Influenza Vaccine Product Overview
9.1.3 Sanofi Influenza Vaccine Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Influenza Vaccine SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Influenza Vaccine Basic Information
9.2.2 CSL Influenza Vaccine Product Overview
9.2.3 CSL Influenza Vaccine Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Influenza Vaccine SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Influenza Vaccine Basic Information
9.3.2 GSK Influenza Vaccine Product Overview
9.3.3 GSK Influenza Vaccine Product Market Performance
9.3.4 GSK Influenza Vaccine SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Influenza Vaccine Basic Information
9.4.2 Viatris Influenza Vaccine Product Overview
9.4.3 Viatris Influenza Vaccine Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Influenza Vaccine Basic Information
9.5.2 AstraZeneca Influenza Vaccine Product Overview
9.5.3 AstraZeneca Influenza Vaccine Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Influenza Vaccine Basic Information
9.6.2 Hualan Bio Influenza Vaccine Product Overview
9.6.3 Hualan Bio Influenza Vaccine Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Influenza Vaccine Basic Information
9.7.2 Changchun Institute of Biological Influenza Vaccine Product Overview
9.7.3 Changchun Institute of Biological Influenza Vaccine Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Influenza Vaccine Basic Information
9.8.2 Sinovac Influenza Vaccine Product Overview
9.8.3 Sinovac Influenza Vaccine Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 BCHT
9.9.1 BCHT Influenza Vaccine Basic Information
9.9.2 BCHT Influenza Vaccine Product Overview
9.9.3 BCHT Influenza Vaccine Product Market Performance
9.9.4 BCHT Business Overview
9.9.5 BCHT Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Influenza Vaccine Basic Information
9.10.2 Jiangsu GDK Influenza Vaccine Product Overview
9.10.3 Jiangsu GDK Influenza Vaccine Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Influenza Vaccine Basic Information
9.11.2 KM Biologics Influenza Vaccine Product Overview
9.11.3 KM Biologics Influenza Vaccine Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
10 INFLUENZA VACCINE MARKET FORECAST BY REGION
10.1 Global Influenza Vaccine Market Size Forecast
10.2 Global Influenza Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Vaccine Market Size Forecast by Region
10.2.4 South America Influenza Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2025-2030)
11.1.2 Global Influenza Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Vaccine by Type (2025-2030)
11.2 Global Influenza Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Influenza Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Influenza Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)
Table 10. Global Market Influenza Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Vaccine Sales Sites and Area Served
Table 12. Manufacturers Influenza Vaccine Product Type
Table 13. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccine Market Challenges
Table 22. Global Influenza Vaccine Sales by Type (Kilotons)
Table 23. Global Influenza Vaccine Market Size by Type (M USD)
Table 24. Global Influenza Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Influenza Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Influenza Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Influenza Vaccine Sales (Kilotons) by Application
Table 30. Global Influenza Vaccine Market Size by Application
Table 31. Global Influenza Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Influenza Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Vaccine Market Share by Application (2019-2024)
Table 35. Global Influenza Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Influenza Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Influenza Vaccine Basic Information
Table 44. Sanofi Influenza Vaccine Product Overview
Table 45. Sanofi Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Influenza Vaccine SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. CSL Influenza Vaccine Basic Information
Table 50. CSL Influenza Vaccine Product Overview
Table 51. CSL Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Influenza Vaccine SWOT Analysis
Table 54. CSL Recent Developments
Table 55. GSK Influenza Vaccine Basic Information
Table 56. GSK Influenza Vaccine Product Overview
Table 57. GSK Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Influenza Vaccine SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Viatris Influenza Vaccine Basic Information
Table 62. Viatris Influenza Vaccine Product Overview
Table 63. Viatris Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. AstraZeneca Influenza Vaccine Basic Information
Table 67. AstraZeneca Influenza Vaccine Product Overview
Table 68. AstraZeneca Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Hualan Bio Influenza Vaccine Basic Information
Table 72. Hualan Bio Influenza Vaccine Product Overview
Table 73. Hualan Bio Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. Changchun Institute of Biological Influenza Vaccine Basic Information
Table 77. Changchun Institute of Biological Influenza Vaccine Product Overview
Table 78. Changchun Institute of Biological Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Changchun Institute of Biological Business Overview
Table 80. Changchun Institute of Biological Recent Developments
Table 81. Sinovac Influenza Vaccine Basic Information
Table 82. Sinovac Influenza Vaccine Product Overview
Table 83. Sinovac Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sinovac Business Overview
Table 85. Sinovac Recent Developments
Table 86. BCHT Influenza Vaccine Basic Information
Table 87. BCHT Influenza Vaccine Product Overview
Table 88. BCHT Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BCHT Business Overview
Table 90. BCHT Recent Developments
Table 91. Jiangsu GDK Influenza Vaccine Basic Information
Table 92. Jiangsu GDK Influenza Vaccine Product Overview
Table 93. Jiangsu GDK Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu GDK Business Overview
Table 95. Jiangsu GDK Recent Developments
Table 96. KM Biologics Influenza Vaccine Basic Information
Table 97. KM Biologics Influenza Vaccine Product Overview
Table 98. KM Biologics Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. KM Biologics Business Overview
Table 100. KM Biologics Recent Developments
Table 101. Global Influenza Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Influenza Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Influenza Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Influenza Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Influenza Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Influenza Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Influenza Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Influenza Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Influenza Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Influenza Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Influenza Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)
Table 10. Global Market Influenza Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Vaccine Sales Sites and Area Served
Table 12. Manufacturers Influenza Vaccine Product Type
Table 13. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccine Market Challenges
Table 22. Global Influenza Vaccine Sales by Type (Kilotons)
Table 23. Global Influenza Vaccine Market Size by Type (M USD)
Table 24. Global Influenza Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Influenza Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Influenza Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Influenza Vaccine Sales (Kilotons) by Application
Table 30. Global Influenza Vaccine Market Size by Application
Table 31. Global Influenza Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Influenza Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Vaccine Market Share by Application (2019-2024)
Table 35. Global Influenza Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Influenza Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Influenza Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Influenza Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Influenza Vaccine Basic Information
Table 44. Sanofi Influenza Vaccine Product Overview
Table 45. Sanofi Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Influenza Vaccine SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. CSL Influenza Vaccine Basic Information
Table 50. CSL Influenza Vaccine Product Overview
Table 51. CSL Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Influenza Vaccine SWOT Analysis
Table 54. CSL Recent Developments
Table 55. GSK Influenza Vaccine Basic Information
Table 56. GSK Influenza Vaccine Product Overview
Table 57. GSK Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Influenza Vaccine SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Viatris Influenza Vaccine Basic Information
Table 62. Viatris Influenza Vaccine Product Overview
Table 63. Viatris Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. AstraZeneca Influenza Vaccine Basic Information
Table 67. AstraZeneca Influenza Vaccine Product Overview
Table 68. AstraZeneca Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Hualan Bio Influenza Vaccine Basic Information
Table 72. Hualan Bio Influenza Vaccine Product Overview
Table 73. Hualan Bio Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. Changchun Institute of Biological Influenza Vaccine Basic Information
Table 77. Changchun Institute of Biological Influenza Vaccine Product Overview
Table 78. Changchun Institute of Biological Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Changchun Institute of Biological Business Overview
Table 80. Changchun Institute of Biological Recent Developments
Table 81. Sinovac Influenza Vaccine Basic Information
Table 82. Sinovac Influenza Vaccine Product Overview
Table 83. Sinovac Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sinovac Business Overview
Table 85. Sinovac Recent Developments
Table 86. BCHT Influenza Vaccine Basic Information
Table 87. BCHT Influenza Vaccine Product Overview
Table 88. BCHT Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BCHT Business Overview
Table 90. BCHT Recent Developments
Table 91. Jiangsu GDK Influenza Vaccine Basic Information
Table 92. Jiangsu GDK Influenza Vaccine Product Overview
Table 93. Jiangsu GDK Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu GDK Business Overview
Table 95. Jiangsu GDK Recent Developments
Table 96. KM Biologics Influenza Vaccine Basic Information
Table 97. KM Biologics Influenza Vaccine Product Overview
Table 98. KM Biologics Influenza Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. KM Biologics Business Overview
Table 100. KM Biologics Recent Developments
Table 101. Global Influenza Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Influenza Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Influenza Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Influenza Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Influenza Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Influenza Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Influenza Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Influenza Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Influenza Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Influenza Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Influenza Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Influenza Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Influenza Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccine Market Size by Country (M USD)
Figure 11. Influenza Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Vaccine Market Share by Type
Figure 18. Sales Market Share of Influenza Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Vaccine by Type in 2023
Figure 20. Market Size Share of Influenza Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Vaccine Market Share by Application
Figure 24. Global Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Vaccine Sales Market Share by Application in 2023
Figure 26. Global Influenza Vaccine Market Share by Application (2019-2024)
Figure 27. Global Influenza Vaccine Market Share by Application in 2023
Figure 28. Global Influenza Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Influenza Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Influenza Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Influenza Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Influenza Vaccine Sales Market Share by Region in 2023
Figure 44. China Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Influenza Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Influenza Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Influenza Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Influenza Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Influenza Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccine Market Size by Country (M USD)
Figure 11. Influenza Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Vaccine Market Share by Type
Figure 18. Sales Market Share of Influenza Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Vaccine by Type in 2023
Figure 20. Market Size Share of Influenza Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Vaccine Market Share by Application
Figure 24. Global Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Vaccine Sales Market Share by Application in 2023
Figure 26. Global Influenza Vaccine Market Share by Application (2019-2024)
Figure 27. Global Influenza Vaccine Market Share by Application in 2023
Figure 28. Global Influenza Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Influenza Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Influenza Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Influenza Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Influenza Vaccine Sales Market Share by Region in 2023
Figure 44. China Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Influenza Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Influenza Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Influenza Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Influenza Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Influenza Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Influenza Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Vaccine Market Share Forecast by Application (2025-2030)
